\u8f89\u745e\u5236\u836fPfizer\uff08NYSE:PFE\uff09<\/a>\uff0c\u6392\u540d\u7b2c\u4e8c\u7684\u827e\u4f2f\u7ef4AbbVie\uff08NYSE:ABBV\uff09\uff0c\u6392\u540d\u7b2c\u4e09\u7684\u5f3a\u751fJohnson & Johnson\uff08NYSE:JNJ\uff09\u3001\u6392\u540d\u7b2c\u516d\u7684\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9dBristol-Myers Squibb\uff08NYSE:BMY\uff09\u4ee5\u53ca\u7b2c\u4e03\u7684\u9ed8\u514bMerck & Co\uff08NYSE:MRK\uff09\u3002<\/p>\n\u6709\u5173\u7a81\u7834\u6027\u533b\u836f\u4ea7\u54c1\uff0c\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7ba1\u5c40\uff08FDA\uff09\u7684\u836f\u54c1\u8bc4\u4ef7\u548c\u7814\u7a76\u4e2d\u5fc32022\u5e74\u6279\u51c6\u4e8637\u79cd\u65b0\u836f\uff0c\u5176\u4e2d\u5f88\u591a\u90fd\u662f\u764c\u75c7\u836f\u7269\u3002\u622a\u81f32023\u5e74\u4e2d\uff0c\u5df2\u83b7\u6279\u7684\u65b0\u836f\u6570\u91cf\u603b\u8ba127\u79cd\u3002\u7f8e\u56fd\u662f\u5168\u7403\u5236\u836f\u7814\u53d1\u7684\u9886\u5bfc\u8005\uff0c\u7814\u53d1\u8d39\u7528\u4ece1980\u5e74\u768420\u4ebf\u7f8e\u5143\u589e\u81f32021\u5e74\u7684796\u4ebf\u7f8e\u5143\u3002\u6b64\u5916\uff0c\u622a\u81f32023\u5e747\u6708\uff0c\u8be5\u56fd\u6ce8\u518c\u7814\u7a76\u548c\u62db\u52df\u4e34\u5e8a\u7814\u7a76\u6570\u91cf\u5206\u522b\u4e3a459343\u4e2a\u548c20696\u4e2a\u3002\u6700\u540e\uff0c\u7f8e\u56fd\u5b8c\u5907\u7684\u77e5\u8bc6\u4ea7\u6743\u4f53\u7cfb\u4ee5\u53ca\u5168\u7403\u98ce\u6295\u5438\u5f15\u529b\u4e3a\u5236\u836f\u884c\u4e1a\u63d0\u4f9b\u4e86\u5f3a\u5927\u7684\u652f\u6301\u3002<\/p>\n
\u6b27\u6d32\u5236\u836f\u884c\u4e1a<\/h2>\n
Fierce Pharma\u7684\u5168\u7403\u524d\u5341\u5927\u5236\u836f\u5546\u540d\u5355\u5f53\u4e2d\uff0c5\u5bb6\u4f4d\u4e8e\u6b27\u6d32\uff0c\u5176\u4e2d\u5305\u62ec\u4f4d\u4e8e\u745e\u58eb\u7684\u6392\u540d\u7b2c\u4e09\u7684Roche\u7f57\u6c0f\uff08OTCQX:RHHBY,SW:ROG\uff09\u4ee5\u53ca\u6392\u540d\u7b2c\u516d\u7684\u8bfa\u534eNovartis\uff08NYSE:NVS\uff09\u3002\u6b64\u5916\uff0c\u82f1\u56fd\u7684\u963f\u65af\u5229\u5eb7AstraZeneca\uff08NASDAQ:AZN\uff09\u548c\u845b\u5170\u7d20\u53f2\u514bGlaxoSmithKline\uff08NYSE:GSK\uff09\u5206\u5217\u7b2c\u4e5d\u548c\u7b2c\u5341\u4f4d\u3002\u6392\u540d\u7b2c\u516b\u4f4d\u7684\u662f\u6cd5\u56fd\u7684\u8d5b\u8bfa\u83f2Sanofi\uff08NASDAQ:SNY\uff09\u3002<\/p>\n
\u6b27\u6d32\u662f\u5168\u7403\u7b2c\u4e8c\u5927\u5236\u836f\u5e02\u573a\uff0c2020\u5e74\u7684\u4ef7\u503c\u8fbe2827.5\u4ebf\u7f8e\u5143\uff0c\u5e76\u4e14\u589e\u957f\u6f5c\u529b\u5de8\u5927\u30022021-2028\u5e74\u671f\u95f4\uff0c\u6b27\u6d32\u5236\u836f\u5e02\u573a\u9884\u8ba1\u5c06\u4ee55.4%\u7684\u5e74\u590d\u5408\u589e\u957f\u7387\uff08CAGR\uff09\u589e\u81f34320\u4ebf\u7f8e\u5143\u4ee5\u4e0a\u3002\u6b64\u5916\uff0c\u6b27\u6d32\u8fd8\u662f\u5168\u7403\u6700\u5927\u7684\u836f\u54c1\u51fa\u53e3\u65b9\uff0c2022\u5e74\u7684\u51fa\u8d27\u91cf\u603b\u8ba13582\u4ebf\u7f8e\u5143\uff0c\u5360\u5168\u7403\u603b\u91cf\u768472.1%\uff0c\u5176\u4e2d\u589e\u901f\u6700\u9ad8\u7684\u6709\u65af\u6d1b\u6587\u5c3c\u4e9a\uff08+113.8%\uff09\u3001\u610f\u5927\u5229\uff08+67.5%\uff09\u548c\u5fb7\u56fd\uff08+32.9%\uff09\u3002<\/p>\n
\u7814\u53d1\u65b9\u9762\uff0c\u6b27\u6d32\u5f88\u591a\u4ea7\u54c1\u90fd\u5c5e\u4e8e\u7814\u53d1\u9636\u6bb5\uff0c\u5176\u4e2d\u6700\u53d7\u5173\u6ce8\u7684\u7a81\u7834\u6027\u521b\u65b0\u662f\u7f57\u6c0f\u65d7\u4e0b\u6cbb\u7597RET\u878d\u5408\u9633\u6027\u665a\u671f\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u6210\u4eba\u60a3\u8005\u7684Gavreto (pralsetinib)\u3002<\/p>\n
\u5168\u7403\u5236\u836f\u884c\u4e1a\u5c55\u671b<\/h2>\n
\u6309\u7167Evaluate Pharma\u7684\u4f30\u7b97\uff0c\u5168\u7403\u5904\u65b9\u836f\u603b\u9500\u552e\u989d\u52302028\u5e74\u9884\u8ba1\u5c06\u63a5\u8fd11.6\u4e07\u4ebf\u7f8e\u5143\uff0c\u5176\u4e2d\u751f\u7269\u5236\u5242\u662f\u4e00\u4e2a\u70ed\u70b9\u3002\u53e6\u5916\u6309\u7167Straits Research\u7684\u9884\u6d4b\uff0c\u80bf\u7624\u836f\u7269\u5e02\u573a\u5c06\u4ee57.7%\u7684\u5e74\u590d\u5408\u589e\u957f\u7387\u589e\u81f32030\u5e74\u76842886.3\u4ebf\u7f8e\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u6700\u8fd1\u51e0\u5e74\uff0c\u4e2d\u56fd\u548c\u5370\u5ea6\u7b49\u5730\u533a\u7684\u5236\u836f\u4e1a\u4e00\u76f4\u5728\u589e\u957f\uff0c\u4f46\u8bf4\u5230\u751f\u547d\u79d1\u5b66\u9886\u57df\u5c24\u5176\u662f\u5236\u836f\u884c\u4e1a\uff0c\u7f8e\u56fd\u548c\u6b27\u6d32\u4f9d\u7136\u662f\u836f\u54c1\u6d88\u8d39\u548c\u5f00\u53d1 […]<\/p>\n","protected":false},"author":27,"featured_media":467622,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,747,925,459],"class_list":["post-467621","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-747","tag-925","tag-459","sectors-life-science-zh-hans","locations-europe-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/467621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=467621"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/467621\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/467622"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=467621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=467621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=467621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}